Investor Presentaiton slide image

Investor Presentaiton

DXd-ADC Technology Grand prize for 6th Bioindustry awards Significant efficacy of ENHERTUⓇ and future potential of DXd-ADC technology are recognized as breakthrough Japan Bioindustry Award バイオインダストリー大賞 DXd-ADC Technology Daiichi-Sankyo 5 researchers at Daiichi Sankyo received the grand prize for Bioindustry for "Innovation of New Generation Antibody Drug Conjugate Technology, DXD-ADC" ➤ This prize is to award an achievement which is expected to have a strong impact on the development of the fields of bioscience, biotechnology and bioindustry ➤ It is the first time that a company alone receive the prize ➤ General Incorporated Association Japan Bioindustry Association announced award on July 15, 2022 Award recipients: Toshinori Agatsuma (Head of Oncology Research Laboratories I, Corporate Officer) Yuki Abe (Head of Oncology Research Laboratories II) ➤ Hiroyuki Naito (Medicinal Chemistry Research Laboratories) Takashi Nakada (Oncology Research Laboratories I) Yusuke Ogitani (Oncology Research Laboratories II) Image is for illustrative purposes only; actual drug to antibody ratio and drug positions may vary. 31
View entire presentation